Hong-Tai Chang

Hong-Tai Chang

Auto-generated profile, based on publicly available information

Hong-Tai Chang

Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2011 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
PDF file
CKChun-Chi Kuo
Chun-Chi Kuo
JHJong-Khing Huang
Jong-Khing Huang
CCChiang-Ting Chou
Chiang-Ting Chou
JCJin-Shiung Cheng
Jin-Shiung Cheng
JTJeng-Yu Tsai
Jeng-Yu Tsai
CJChung-Ren Jan
Chung-Ren Jan
The effect of the environmental contaminant, bisphenol A, on cytosolic free Ca2+ concentrations ([Ca2+]i) in Madin-Darby canine kidney (MDCK) cells is unclear. This study explored whether bisphenol A changed basal [Ca2+]i levels in suspended MDCK cells by using fura-2 as a Ca2+-sensitive fluorescent dye. Bisphenol A, at concentrations between 50 and 300 µM, increased [Ca2+]i in a concentration-dependent manner. The Ca2+ signal was reduced, partly, by removing extracellular Ca2+. Bisphenol A induced Mn2+ influx, leading to quenching of fura-2 fluorescence, suggesting Ca2+ influx. This Ca2+ influx was inhibited by phospholipase A2 inhibitor aristolochic acid, store-operated Ca2+ channel blockers nifedipine and SK&F96365, and protein kinase C inhibitor GF109203X. In Ca2+-free medium, pretreatment with the mitochondrial uncoupler, carbonylcyanide m-chlorophenylhydrazone (CCCP), and the endoplasmic reticulum Ca2+ pump inhibitors, thapsigargin or 2,5-di-tert-butylhydroquinone (BHQ), inhibited bisphenol A–induced Ca2+ release. Conversely, pretreatment with bisphenol A abolished thapsigargin (or BHQ)- and CCCP-induced [Ca2+]i rise. Inhibition of phospholipase C with U73122 abolished bisphenol-induced [Ca2+]i rise. Bisphenol A caused a concentration-dependent decrease in cell viability via apoptosis in a Ca2+-independent manner. Collectively, in MDCK cells, bisphenol A induced [Ca2+]i rises by causing phospholipase C–dependent Ca2+ release from the endoplasmic reticulum and mitochondria and Ca2+ influx via phospholipase A2–, protein kinase C–sensitive, store-operated Ca2+ channels.

1 March 2005 in Life Sciences
Verified
Journal Article
Closed access
HCHong-Tai Chang
Hong-Tai Chang
WCWei-Chung Chen
Wei-Chung Chen
JCJin-Shyr Chen
Jin-Shyr Chen
YLYih-Chau Lu
Yih-Chau Lu
SHShu-Shong Hsu
Shu-Shong Hsu
CJChung-Ren Jan
Chung-Ren Jan

1 October 2009 in Toxicology in Vitro
Verified
Journal Article
Closed access
KLKOLONG LIN
KOLONG LIN
CHChorng-Chih Huang
Chorng-Chih Huang
JCJin-Shiung Cheng
Jin-Shiung Cheng
JTJeng-Yu Tsai
Jeng-Yu Tsai
YLYih-Chau Lu
Yih-Chau Lu
CJChung-Ren Jan
Chung-Ren Jan

4 October 2002 in Pharmacology
Verified
Journal Article
Closed access
PDF file
CJChung-Ren Jan
Chung-Ren Jan
YLYih-Chau Lu
Yih-Chau Lu
BJBang-Ping Jiann
Bang-Ping Jiann
HCHong-Tai Chang
Hong-Tai Chang
JHJong-Khing Huang
Jong-Khing Huang
In human osteosarcoma MG63 cells, the effect of the neuroprotective drug riluzole on the intracellular Ca2+ concentration ([Ca2+]i) was measured using fura-2. Riluzole (50–500 µmol/l) caused a rapid and sustained plateau increase in [Ca2+]i in a concentration-dependent manner (EC50 = 150 µmol/l). The riluzole-induced rise in [Ca2+]i was prevented by 58 and 20% by extracellular Ca2+ removal and nifedipine, respectively, but was not changed by La3+ and verapamil. In Ca2+-free medium, thapsigargin, an inhibitor of the endoplasmic reticulum (ER) Ca2+-ATPase, caused a monophasic increase in [Ca2+]i, after which the increasing effect of riluzole on [Ca2+]i was attenuated by 84%; also, pretreatment with riluzole abolished the thapsigargin-induced [Ca2+]i increase. U73122, an inhibitor of phospholipase C, abrogated the ATP (but not riluzole)-induced rise in [Ca2+]i. A low concentration (6 µmol/l) of riluzole selectively potentiated the bradykinin (but not ATP and histamine)-induced increase in [Ca2+]i. These results suggest that riluzole rapidly increases [Ca2+]i by stimulating both the extracellular Ca2+ influx via a nifedipine-sensitive pathway and intracellular Ca2+ release from the ER via an as yet unidentified mechanism(s).

1 March 2016 in Medicine
Verified
Journal Article
Open access
Tsung-Jung LiangTsung-Jung Liang
Tsung-Jung Liang
SLShiuh-Inn Liu
Shiuh-Inn Liu
CTChung-Yu Tsai
Chung-Yu Tsai
CKChi-Hsiang Kang
Chi-Hsiang Kang
WHWei-Chun Huang
Wei-Chun Huang
ICI-Shu Chen Chen
I-Shu Chen Chen
The recurrence rate for acute appendicitis treated nonoperatively varies between studies. Few studies have adequately evaluated the management of these patients when appendicitis recurs. We aimed to explore the recurrence rate and management of patients with acute appendicitis that were first treated nonoperatively.We identified patients in the Taiwan National Health Insurance Research Database who were hospitalized due to acute appendicitis for the first time between 2000 and 2010 and received nonsurgical treatment. The recurrence and its management were recorded. Data were analyzed to access the risk factors for recurrence and factors that influenced the management of recurrent appendicitis.Among the 239,821 patients hospitalized with acute appendicitis for the first time, 12,235 (5.1%) patients were managed nonoperatively. Of these, 864 (7.1%) had a recurrence during a median follow-up of 6.5 years. Appendectomy was performed by an open and laparoscopic approach in 483 (55.9%) and 258 (29.9%) patients, respectively. The remaining 123 (14.2%) patients were again treated nonsurgically. Recurrence was independently associated with young age, male sex, percutaneous abscess drainage, and medical center admission by multivariable analysis. In addition, age <18, a (CCI) <2, medical center admission, and a longer time to recurrence were correlated with using laparoscopy to treat recurrence. Neither type of appendicitis, percutaneous abscess drainage, nor length of first time hospital stay had an influence on the selection of surgical approach.In conclusion, a laparoscopic appendectomy can be performed in recurrent appendicitis cases, and its application may not be related to previous appendicitis severity.

1 February 2003 in Life Sciences
Verified
Journal Article
Closed access
SKSoong-Yu Kuo
Soong-Yu Kuo
BJBang-Ping Jiann
Bang-Ping Jiann
YLYih-Chau Lu
Yih-Chau Lu
HCHong-Tai Chang
Hong-Tai Chang
WCWei-Chung Chen
Wei-Chung Chen
CJChung-Ren Jan
Chung-Ren Jan